|
Ivaschenko D.V., Aysin F.R., Byalkovskaya P.A., Gragyants B.R., Shevchenko Yu.S., Sychev D.A.
Age-specific safety of pharmacotherapy for behavioral disorders in children and adolescents: a retrospective study
|
№7 / 2025
|
|
Vlasova A.V., Kameneva T.R., Yakovlev S.V.
Promising directions for the use of intravenous fosfomycin in children
|
№7 / 2025
|
|
Ivashchenko D.V., Zimina P.A., Illarionova M.E., Kuzmin I.I., Miroshnichenko I.I., Sychev D.A.
Steady-state plasma bromdihydrochlorophenylbenzodiazepine concentrations in men with alcohol withdrawal syndrome: impact on safety
|
№4 / 2025
|
|
Vladimirova I.S., Kruglova L.S.
Psoriasis of special localizations and the effectiveness of the IL-23 inhibitor guselkumab in clinical practice
|
№10 / 2024
|
|
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
|
№2 / 2024
|
|
D.V. Ivashchenko, A.Yu. Kravchenko, S.Z. Khoang, N.I. Buromskaya, P.V. Shimanov, R.V. Deitch, M.I. Nastovich, K.A. Akmalova, A.A Kachanova, L.M. Savchenko, Yu.S. Shevchenko, D.A. Sychev
Pharmacogenetic factors of haloperidol’s safety in adolescents experiencing acute psychotic episodes
|
№4-5 / 2023
|
|
L.S. Kruglova (1), A.A. Khotko (2), N.S. Rudneva (3)
Are the goals of psoriasis treatment achievable in real clinical practice?
|
№14 / 2021
|
|
L.S. Kruglova (1), N.S. Tataurschikova (2), E.V. Tipaeva (3)
Issues of long-term use of antihistamines
|
№14 / 2021
|
|
D.V. Ivashchenko (1, 2), N.I. Buromskaya (3), P.V. Shimanov (3), R.V. Deich (3), I.V. Dorina (3), M.I. Nastovich (3), K.A. Akmalova (1), A.A. Kachanova (1), E.A. Grishina (1), L.M. Savchenko (1), Yu.S. Shevchenko (1), D.A. Sychev (1)
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
|
№11 / 2021
|
|
A.S. Kulakova, D.L. Bentsion, V.G. Elishev, V.A. Vetrov
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg
|
№11 / 2021
|
|
D.N. Andreev, I.V. Mayev, A.A. Samsonov, E.G. Lobanova, E.V. Partsvania-Vinogradova
SAFETY OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION: SYSTEMATIZATION OF LITERATURE DATA
|
№13 / 2017
|
|
G.L.Yurenev, D.N. Andreev, E.V. Partsvaniya-Vinogradova, D.T. Dicheva
HYBRID SCHEME OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION: SYSTEMATIZATION OF LITERATURE DATA
|
№2 / 2017
|
Русский
